KIDRON NADAV
SEC CIK 1351779 · EDGAR
BoughtSold
Most active insiders at NNDM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Borenstein Phillip | Dir | — | — |
| 2 | Rosensweig Joshua | Dir | — | — |
| 3 | Brenton John | CFO | — | — |
| 4 | Sriubas Andrew | Dir | — | — |
| 5 | Stehlin David | CEO, Dir | — | — |
| 6 | KIDRON NADAV | Dir | — | — |
| 7 | PONS ROBERT M | Dir | — | — |
Transactions 29
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-25 18:08 | 2026-08-21 | NNDM | Nano Dimension Ltd. | KIDRON NADAV | Dir | X - OptEx | $1.50 | -10.0K | 30.0K | -25% | -$15.0K |
| 2026-03-31 | 2026-03-30 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | F - Tax | $3.31 | -44.8K | 3.42M | -1% | -$148.3K | |
| 2026-03-27 | 2026-03-25 | LFWD | Lifeward Ltd. | KIDRON NADAV | Dir | A - Grant | $0.00 | +7,657 | 7,657 | New | $0 | |
| 2026-03-18 | 2026-03-17 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | A - Grant | $0.00 | +167.0K | 3.42M | +5% | $0 | |
| 2026-03-16 | 2026-03-12 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | G - Gift | $0.00 | -100.0K | 3.26M | -3% | $0 | |
| D | 2026-01-29 | 2026-01-22 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | M - OptEx | $0.00 | +109.0K | 3.36M | +3% | $0 |
| DM | 2026-01-05 | 2025-12-31 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | A - Grant | $0.00 | +559.6K | 2.92M | +24% | $0 |
| M | 2025-02-11 | 2025-02-11 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | A - Grant | $0.00 | +427.0K | 2.59M | +20% | $0 |
| 2025-01-06 | 2025-01-02 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | A - Grant | — | +433.5K | 2.26M | +24% | — | |
| 2024-11-08 | 2024-11-07 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | A - Grant | — | +45.0K | 1.83M | +3% | — | |
| 2024-01-08 | 2024-01-04 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | A - Grant | — | +329.0K | 1.78M | +23% | — | |
| 2023-05-31 | 2023-05-26 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | A - Grant | — | +120.0K | 1.45M | +9% | — | |
| 2023-04-20 | 2023-04-17 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | A - Grant | — | +279.0K | 1.33M | +26% | — | |
| I | 2023-03-16 | 2023-03-16 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | P - Purchase | $2.04 | +26.0K | 126.0K | +26% | +$53.0K |
| I | 2023-03-15 | 2023-03-14 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | P - Purchase | $2.01 | +100.0K | 100.0K | New | +$201.0K |
| 2022-10-28 | 2022-10-27 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | G - Gift | $0.00 | -25.0K | 1.05M | -2% | $0 | |
| 2022-08-01 | 2022-08-01 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | F - Tax | $8.36 | -12.6K | 1.08M | -1% | -$105.6K | |
| M | 2022-08-01 | 2022-07-28 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | A - Grant | — | +160.0K | 1.09M | +17% | — |
| DA | 2022-01-11 | 2022-01-03 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | F - Tax | $13.89 | -48.8K | 867.7K | -5% | -$677.2K |
| DMA | 2022-01-11 | 2022-01-03 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | A - Grant | — | +213.0K | 916.5K | +30% | — |
| DM | 2022-01-05 | 2022-01-03 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | A - Grant | — | +213.0K | 936.5K | +29% | — |
| D | 2022-01-05 | 2022-01-03 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | F - Tax | $13.89 | -48.8K | 887.7K | -5% | -$677.2K |
| 2021-12-30 | 2021-12-28 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | F - Tax | $12.98 | -31.7K | 786.5K | -4% | -$411.8K | |
| 2021-12-30 | 2021-12-30 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | G - Gift | — | -20.0K | 766.5K | -3% | — | |
| A | 2021-12-07 | 2021-08-31 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | A - Grant | — | +100.0K | 838.2K | +14% | — |
| A | 2021-12-07 | 2021-08-09 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir, 10% | S - Sale | $20.11 | -220.0K | 738.2K | -23% | -$4.42M |
| 2021-12-07 | 2021-12-03 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | G - Gift | — | -20.0K | 818.2K | -2% | — | |
| 2021-09-02 | 2021-08-31 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir | A - Grant | — | +100.0K | 748.6K | +15% | — | |
| 2021-08-11 | 2021-08-09 | ORMP | ORAMED PHARMACEUTICALS INC. | KIDRON NADAV | Pres, CEO, Dir, 10% | S - Sale | $20.11 | -220.0K | 648.6K | -25% | -$4.42M |
Purchase Sale Sale after option exercise All abbreviations